 |
|
Oxygen + MRI might help determine cancer therapy success
June 03, 2009A simple magnetic resonance imaging (MRI) test involving breathing oxygen might help oncologists determine the best treatment for some cancer patients, report researchers at UT Southwestern Medical Center.
Prior research has shown that the amount of oxygen present in a tumor can be a predictor of how well a patient will respond to treatment. Tumors with little oxygen tend to grow stronger and resist both radiotherapy and chemotherapy. Until now, however, the only way to gauge the oxygen level in a tumor, and thus determine which treatment might be more effective, was to insert a huge needle directly into the cancerous tumor.
The new technique, known as BOLD (blood oxygen level dependent) MRI, can detect oxygen levels in tumors without the need for an invasive procedure. The patient need only be able to breathe in oxygen when undergoing an MRI.
"The patient simply inhales pure oxygen, which then circulates through the bloodstream, including to the tumors," said Dr. Ralph Mason, professor of radiology, director of the UT Southwestern Cancer Imaging Center and senior author of a study appearing online and in a future edition of Magnetic Resonance in Medicine. "Using MRI, we can then go in and estimate how much oxygen a particular tumor is taking up, providing us some insight into how the tumor is behaving and what sort of treatment might be effective."
The most important finding, Dr. Mason said, is that BOLD MRI performed as well as the standard yet more invasive procedure for viewing tumors. That method, known as FREDOM (fluorocarbon relaxometry using echo planar imaging for dynamic oxygen mapping) MRI, requires the injection of a chemical called a reporter molecule directly into the tumor.
"The BOLD technique appears to indicate accurately the oxygen levels in tumors," Dr. Mason said. "Because BOLD is immediately applicable to patients, this holds promise as a new method for predicting response to therapy."
BOLD MRI has been used extensively in studying brain function, but the procedure has only recently begun to be used to assess blood oxygenation and vascular function in tumors.
Physicians at UT Southwestern are already testing BOLD MRI in patients with cervical, prostate, and head and neck cancer. They have proposed using it in lung cancer patients as well, Dr. Mason said. Previous research has shown that those specific tumor types are more likely to have little oxygen.
In the published study, researchers took multiple images of breast tumors implanted just below the skin of rats, which were given anesthesia to help them remain still during the imaging process. Humans do not require anesthesia, Dr. Mason said.
Dr. Mason said the team took the research back to the preclinical stage because they needed to better define what physicians were seeing in the clinic and whether the findings were reproducible.
Dr. Mason said that examining each form of cancer in this way presents its own technical challenges. For example, the motion of the lungs or the design of a face mask for breathing oxygen must be taken into account.
"If we can prove that the test is meaningful in animals, then it is that much more worthwhile to argue for doing it in a patient. This preclinical work provides the foundation for future clinical studies," Dr. Mason said. "It helps justify doing a larger clinical trial with the goal of ultimately becoming a diagnostic test for oncologists."
Researchers currently are trying to determine how much oxygen must be inhaled by a patient in order to be effective. The next step is to expand studies in patients and prove the relevance to more tumor types.
Other UT Southwestern researchers involved in the research were Dr. Dawen Zhao, lead author and assistant professor of radiology; Dr. Lan Jiang, a postdoctoral researcher in radiation oncology; and Dr. Eric Hahn, consultant in radiology.
The work was supported by the Department of Defense and the National Cancer Institute. The MRI experiments were performed in UT Southwestern's Advanced Imaging Research Center, an NIH-funded basic and translational research facility.
Visit http://www.utsouthwestern.org/radiology to learn more about UT Southwestern's clinical services in radiology, including oncology imaging. Visit http://www.utsouthwestern.org/cancercenter to learn more about clinical services in cancer at UT Southwestern.
UT Southwestern Medical Center
"The patient simply inhales pure oxygen, which then circulates through the bloodstream, including to the tumors," said Dr. Ralph Mason, professor of radiology, director of the UT Southwestern Cancer Imaging Center and senior author of a study appearing online and in a future edition of Magnetic Resonance in Medicine. "Using MRI, we can then go in and estimate how much oxygen a particular tumor is taking up, providing us some insight into how the tumor is behaving and what sort of treatment might be effective."
The most important finding, Dr. Mason said, is that BOLD MRI performed as well as the standard yet more invasive procedure for viewing tumors. That method, known as FREDOM (fluorocarbon relaxometry using echo planar imaging for dynamic oxygen mapping) MRI, requires the injection of a chemical called a reporter molecule directly into the tumor.
"The BOLD technique appears to indicate accurately the oxygen levels in tumors," Dr. Mason said. "Because BOLD is immediately applicable to patients, this holds promise as a new method for predicting response to therapy."
BOLD MRI has been used extensively in studying brain function, but the procedure has only recently begun to be used to assess blood oxygenation and vascular function in tumors.
Physicians at UT Southwestern are already testing BOLD MRI in patients with cervical, prostate, and head and neck cancer. They have proposed using it in lung cancer patients as well, Dr. Mason said. Previous research has shown that those specific tumor types are more likely to have little oxygen.
In the published study, researchers took multiple images of breast tumors implanted just below the skin of rats, which were given anesthesia to help them remain still during the imaging process. Humans do not require anesthesia, Dr. Mason said.
Dr. Mason said the team took the research back to the preclinical stage because they needed to better define what physicians were seeing in the clinic and whether the findings were reproducible.
Dr. Mason said that examining each form of cancer in this way presents its own technical challenges. For example, the motion of the lungs or the design of a face mask for breathing oxygen must be taken into account.
"If we can prove that the test is meaningful in animals, then it is that much more worthwhile to argue for doing it in a patient. This preclinical work provides the foundation for future clinical studies," Dr. Mason said. "It helps justify doing a larger clinical trial with the goal of ultimately becoming a diagnostic test for oncologists."
Researchers currently are trying to determine how much oxygen must be inhaled by a patient in order to be effective. The next step is to expand studies in patients and prove the relevance to more tumor types.
Other UT Southwestern researchers involved in the research were Dr. Dawen Zhao, lead author and assistant professor of radiology; Dr. Lan Jiang, a postdoctoral researcher in radiation oncology; and Dr. Eric Hahn, consultant in radiology.
The work was supported by the Department of Defense and the National Cancer Institute. The MRI experiments were performed in UT Southwestern's Advanced Imaging Research Center, an NIH-funded basic and translational research facility.
Visit http://www.utsouthwestern.org/radiology to learn more about UT Southwestern's clinical services in radiology, including oncology imaging. Visit http://www.utsouthwestern.org/cancercenter to learn more about clinical services in cancer at UT Southwestern.
UT Southwestern Medical Center
Cancer Therapy Current Events and Cancer Therapy News RSSShort-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone.
Duke develops nano-scale drug delivery for chemotherapy
Going smaller could bring better results, especially when it comes to cancer-fighting drugs.
Experts issue call to reconsider screening for breast cancer and prostate cancer
Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."
Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy
The human genetic disease dyskeratosis congenita (DKC) is an autosomal dominant disease that leads to abnormalities in tissues with a rapid cell turnover - the skin, nails, bone marrow, lungs and gut.
October 15, 2009 Loss of Tumor-Suppressor and DNA-Maintenance Proteins Causes Tissue Demise, Penn Study Finds
A study published in the October issue of Nature Genetics demonstrates that loss of the tumor-suppressor protein p53, coupled with elimination of the DNA-maintenance protein ATR, severely disrupts tissue maintenance in mice. As a result, tissues deteriorate rapidly, which is generally fatal in these animals. In addition, the study provides supportive evidence for the use of inhibitors of ATR in cancer therapy.
Transcendental meditation reduces stress, improves mental health among women with breast cancer
Women with breast cancer reduced stress and improved their mental health and emotional well being through the Transcendental Meditation technique.
Survivors of childhood cancer less likely to marry
Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar.
Molecular imaging holds promise for early intervention in common uterine cancer
A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors.
Penn studies point to strategies for reducing painful breast cancer drug side effects
Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines.
Therapeutic nanoparticles give new meaning to sugar-coating medicine
A research team at the National Institute of Standards and Technology (NIST) studying sugar-coated nanoparticles for use as a possible cancer therapy has uncovered a delicate balancing act that makes the particles more effective than conventional thinking says they should be.
More Cancer Therapy Current Events and Cancer Therapy News Articles
 |
A Cancer Therapy: Results of Fifty Cases and the Cure of Advanced Cancer by Max Gerson (Author) |
 |
Cancer Therapy: The Independent Consumer's Guide to Non-Toxic Treatment & Prevention by Ralph W. Moss (Author) This thorough guide is a must-read for cancer patients and their families seeking treatment options. |
 |
Everyone's Guide to Cancer Therapy; Revised 5th Edition: How Cancer Is Diagnosed, Treated, and Managed Day to Day by M.d., Ernest H. Rosenbaum (Author), Malin Dollinger (Author) The Centers for Disease Control reports that more than 20 million people in the U.S. are currently diagnosed with cancer, and 1.4 million people are expected to be diagnosed in the coming year. For the millions confronting cancer's many challenges, Everyone's Guide to Cancer Therapy: How Cancer Is Diagnosed, Treated, and Managed Day to Day relies on an esteemed panel of oncology specialists--more than 100 strong, and each experts in their fields--to completely update this definitive cancer resource. Equally informative and accessible, this comprehensive book navigates cancer patients and their caregivers through diagnosis, treatment, and supportive care. Every chapter has been methodically updated to include the latest medical breakthroughs and advice concerning cancer treatment,... |
 |
The Gerson Therapy: The Proven Nutritional Program for Cancer and Other Illnesses by Charlotte Gerson (Author), D.P.M., Morton Walker (Author) Cancer. Hepatitis. Migraines. Arthritis. Heart Disease. Emphysema. For years, the medical establishment has called these chronic or life- threatening diseases "incurable." But now, the Gerson Therapy offers hope for those seeking relief from hundreds of different diseases. Juice your way to wellness. One of the first alternative cancer therapies, the Gerson Therapy has successfully treated thousands of patients for over 60 years. Now, in this authoritative revised and updated edition, alternative medicine therapist Charlotte Gerson and medical journalist Morton Walker reveal even more on the powerful healing effects of organic fruits and vegetables. Not only can juicing reverse the effects of many degenerative illnesses-it can save lives. "The Gerson Therapy" shows you: How to beat cancer... |
|
Annals of Cancer Research and Therapy by Pjd Publs Ltd | |
 |
Targeted Cancer Therapy Part of the award winning public television series Healthy Body/Healthy Mind. For dozens of years, the most common forms of cancer treatments included traditional chemotherapy, radiation and possibly surgery. Now newer medications are emerging, thanks to advances in science. Research has brought about a better understanding of cancer on a molecular level. This understanding is resulting in medicines that zero in on properties unique to cancer cells, allowing those medicines to selectively affect cancer with the potential of less collateral damage to healthy cells in the body. This program, "Targeted Cancer Therapy," describes how targeted therapies work, and introduces patients and families who are finding hope and healing where there once was none. This product is manufactured on... |
 |
Verilux TwiLight Mini Ultra Blue Light Therapy Sleep System by Verilux The TwiLight Mini Ultra Blue Light Therapy Sleep System provides excellent blue light exposure that has been shown to optimize the re-calibration of the body's Circadian rhythm. Many studies have shown that the occurrence of sleep disturbance increase with age. The natural Circadian rhythm that regulates your body's sleep cycles can be thrown off by spending more time indoors as we age. Placing this compact device in your bedroom and activating its soothing blue light for 30-60 minutes prior to falling asleep will help you fall asleep faster and experience a more satisfying slumber. Young children and infants can also benefit from bathing their bedroom in the soft glow of blue light to falling asleep. The TwiLight System remains cool to the touch, so it's safe to use. The compact size... |
 |
Cancer Be Gone Guided imagery CD taps into the immense power of the mind to enhance comfort, healing, an optimistic attitude and positive expectations. Metaphor of "cancer as weeds in a garden that are easily managed". |
 |
My Journey with Breast Cancer by Jo Ann Klein, MS, RN My journey with breast cancer from diagnosis to treatment to every day living. Must reading for the newly diagnosed.Kindle blogs are fully downloaded onto your Kindle so you can read them even when you're not wirelessly connected. And unlike RSS readers which often only provide headlines, blogs on Kindle give you full text content and images, and are updated wirelessly throughout the day. |
|
Complementary Therapies for Cancer PA [VHS] Starring: Various |
| © 2009 BrightSurf.com |